A large pharmaceutical client was managing a delayed launch for one of their products and was concerned that their original market access strategy may be misaligned due to evolving external factors, such as market dynamics and payer strategies. Given their familiarity with our expertise, the client reached out to Vynamic to conduct a comprehensive assessment of each factor and propose a refreshed market access strategy to enable a successful launch.
A proper market access strategy can make or break a product’s launch. With market conditions rapidly evolving and the approval pending, we needed to apply a quick and nimble approach leveraging Vynamic’s Strategic Planning & Mobilization service. In doing so, Vynamic partnered closely with the market access team and other relevant functions to quickly assess key factors and make recommendations for a refreshed market access strategy.
There were four key activities:
Identify and Confirm the Key Factors
Vynamic aligned with leadership on the rationale to revisit the original strategy by understanding the underlying assumptions and key changes within. Using that as the foundation, we identified and prioritized the factors to assess based on their potential impact to the market access strategy.
Conduct Factor Deep Dives
Vynamic then completed a detailed assessment of the key factors (e.g., competitive landscape, payer strategies for formulary management, account team insights, etc.) to understand how they were evolving and assessed the readiness and position of our client against those changes.
Recommend Updates to Access Strategy
Based on the deep dive analysis, Vynamic defined recommendations to adjust the product’s overall market access approach, revise goals, and define an account specific strategy based on anticipated payer contracting.
Implement a Leadership Dashboard & Governance Framework
Vynamic designed a dashboard for franchise and cross-functional leadership to review and monitor their strategy based on key metrics and stood up the supporting forums for periodic reviews and action-oriented discussions.
Our client implemented the recommendations and communicated the refreshed market access strategy to relevant internal teams to ensure readiness and adoption prior to launch. The ongoing monitoring and governance framework was also key to allowing the client to remain nimble by proactively responding to the market based on evolving trends and metrics. As a result of our strategic thinking, collaborative partnership with this client, and extensive knowledge of market access and product launch, Vynamic has continued to support this franchise team for additional launch needs.
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
In the Medicare Advantage B2C market, learn how Vynamic streamlined touchpoints and cut costs while enhancing satisfaction
A global gene therapy client partnered with Vynamic to optimize its engagement with treatment centers in preparation for a product launch.
A medical technology company engaged Vynamic to assess and improve their sales communication processes to capitalize on a favorable market position.